Cost of OraQuick oral fluid rapid HIV testing at 35 community clinics and community-based organizations in the USA

AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

Volumn 21, Issue 9, 2009, Pages 1157-1162

  Pinkerton, Steven D ^a   Bogart, Laura M ^b,c   Howerton, Devery ^d   Snyder, Susan ^d   Becker, Kirsten ^b   Asch, Steven M ^b,e,f  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b RAND CORPORATION   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Community based organizations; Cost; HIV; Rapid testing

Indexed keywords

ARTICLE; ASSAY; COMMUNITY; COST BENEFIT ANALYSIS; ECONOMICS; HEALTH CARE COST; HEALTH CARE ORGANIZATION; HEALTH CARE POLICY; HUMAN IMMUNODEFICIENCY VIRUS; LIQUID; MEDICAL INSTRUMENTATION; MONEY; OUTPATIENT DEPARTMENT; PRIORITY JOURNAL; SAMPLE; UNITED STATES;

AIDS SERODIAGNOSIS; AMBULATORY CARE; COMMUNITY HEALTH SERVICES; COST OF ILLNESS; COST-BENEFIT ANALYSIS; HIV INFECTIONS; HUMANS; SENSITIVITY AND SPECIFICITY;

EID: 70449627208     PISSN: 09540121     EISSN: 13600451     Source Type: Journal    
DOI: 10.1080/09540120902729940     Document Type: Article

References (20)

1. Bogart, L.M., Howerton, D., Lange, J., Becker, K., Setodji, C.M., & Asch, S.M. (2008). Scope of rapid HIV testing in private nonprofit urban community health settings in the United States. American Journal of Public Health, 98, 736-742.
2. Centers for Disease Control and Prevention. (2002). Approval of a new rapid test for HIV antibody. Morbidity and Mortality Weekly Report, 51, 1051-1052.
3. Centers for Disease Control and Prevention. (2003). Advancing HIV prevention: New strategies for a changing epidemic-United States, 2003. Morbidity and Mortality Weekly Report, 52, 329-332.
4. Centers for Disease Control and Prevention. (2006). Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. Morbidity and Mortality Weekly Report, 55, 1-17.
5. Crepaz, N., Lyles, C.M., Wolitsky, R.J., Passin, W.F., Rama, S.M., Herbst, J.H., et al. (2006). Do prevention interventions reduce HIV risk behaviours among people living with HIV? A meta-analytic review of controlled trials. AIDS, 20, 143-157.
6. Donovan, B.J., Rublein, J.C., Leone, P.A., & Pilcher, C.D. (2004). HIV infection: Point-of-care testing. Annals of Pharmacotherapy, 38, 670-676.
7. Dybul, M., Fauci, A.S., Bartlett, J.G., Kaplan, J.E., & Pau, A.K. (2002). Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Annals of Internal Medicine, 137, 381-433.
8. Ekwueme, D.U., Pinkerton, S.D., Holtgrave, D.R., & Branson, B.M. (2003). Cost comparison of three HIV counseling and testing technologies. American Journal of Preventive Medicine, 25, 112-121.
9. Farnham, P.G., Gorsky, R.D., Holtgrave, D.R., Jones, W.K., & Guinan, M.E. (1996). Counseling and testing for HIV prevention: Costs, effects, and cost-effectiveness of more rapid screening tests. Public Health Reports, 111, 44-53.
10. Greenwald, J.L., Burstein, G.R., Pincus, J., & Branson, B. (2006). A rapid review of rapid HIV antibody tests. Current Infectious Disease Reports, 8, 125-131.
11. Health Research & Educational Trust. (2008). Charts comparing rapid HIV antibody screening tests. Retrieved April 7, 2008, from www.hret.org/hret/ programs/ hivtransmrpd.html.
12. Hutchinson, A.B., Branson, B.M., Kim, A., & Farnham, P.G. (2006). A meta-analysis of the effectiveness of alternative HIV counseling and testing methods to increase knowledge of HIV status. AIDS, 20, 1597-1604.
13. Janssen, R.S., Holtgrave, D.R., Valdiserri, R.O., Shepherd, M., Gayle, H.D., & De Cock, K.M. (2001). The serostatus approach to fighting the HIV epidemic: Prevention strategies for infected individuals. American Journal of Public Health, 91, 1019-1024.
14. Kelen, G.D., Shahan, J.B., & Quinn, T.C. (1999). Emergency department-based HIV screening and counseling: Experience with rapid and standard serologic testing. Annals of Emergency Medicine, 33, 147-155.
15. Marks, G., Crepaz, N., & Janssen, R.S. (2006). Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA. AIDS, 20, 1447-1450.
16. Palella Jr. F.J., Delaney, K.M. Moorman, A.C. Loveless, M.O., Fuhrer, J. Satten, G.A. et al. (1998). Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. New England Journal of Medicine, 338, 853-860.
17. Paltiel, A.D., Weinstein, M.C., Kimmel, A.D., Seage, G.R., Losina, E., Zhang, H., et al. (2005). Expanded screening for HIV in the United States- an analysis of costeffectiveness. New England Journal of Medicine, 352, 586-589.
18. Pinkerton, S.D., Holtgrave, D.R., & Galletly, C.L. (2008). Infections prevented by increasing HIV serostatus awareness in the U.S., 2001 to 2004. Journal of Acquired Immune Deficiency Syndrome, 47(3), 354-7.
19. Shrestha, R.K., Sansom, S.L., Richardson-Moore, A., French, P.T., Scalco, B., Lalota, M., et al. (2009). Costs of voluntary rapid HIV testing and counseling in jails in 4 states-Advancing HIV prevention demonstration project, 2003-2006. Sexually Transmitted Diseases, 36(Suppl. 2), S5-S8.
20. Varghese, B., Peterman, T.A., & Holtgrave, D.R. (1999). Cost-effectiveness of counseling and testing and partner notification: A decision analysis. AIDS, 13, 1745-1751.